Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
Michael Wang, Javier Munoz, Andre Goy, Frederick Locke, Caron A. Jacobson, Brian T. Hill, John M. Timmerman, Houston Holmes, Samantha Jaglowski, Ian W. Flinn, Peter A. Mcsweeney, David B. Miklos, John M. Pagel, Marie José Kersten, Krimo Bouabdallah, Rashmi Khanal, Roch Houot, Amer Beitinjaneh, Weimin Peng, Xiang FangRhine R. Shen, Rubina Siddigi, Ioana Kloos, Patrick M. Reagan
Research output: Contribution to journal › Article › peer-review
216Scopus
citations
Fingerprint
Dive into the research topics of 'Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study'. Together they form a unique fingerprint.